These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 29305845)
1. Serum CTRP3 level is inversely associated with nonalcoholic fatty liver disease: A 3-y longitudinal study. Zhou W; Wang Y; Wu Y; Yang J; Xu L; Yang Y Clin Chim Acta; 2018 Apr; 479():79-83. PubMed ID: 29305845 [TBL] [Abstract][Full Text] [Related]
2. Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Zhang J; Zhang B; Cheng Y; Xu J Cytokine; 2018 Jun; 106():131-135. PubMed ID: 29113741 [TBL] [Abstract][Full Text] [Related]
3. Serum CTRP3 Level is Associated with Osteoporosis in Postmenopausal Women. Xu ZH; Zhang X; Xie H; He J; Zhang WC; Jing DF; Luo X Exp Clin Endocrinol Diabetes; 2018 Oct; 126(9):559-563. PubMed ID: 29421828 [TBL] [Abstract][Full Text] [Related]
4. C1q/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality. Gao C; Zhao S; Lian K; Mi B; Si R; Tan Z; Fu F; Wang S; Wang R; Ma X; Tao L BMC Cardiovasc Disord; 2019 Jun; 19(1):139. PubMed ID: 31182031 [TBL] [Abstract][Full Text] [Related]
5. Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels. Luo YQ; Ma XJ; Hao YP; Pan XP; Xu YT; Xiong Q; Bao YQ; Jia WP Acta Pharmacol Sin; 2015 Dec; 36(12):1497-502. PubMed ID: 26567728 [TBL] [Abstract][Full Text] [Related]
6. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. Kwak MS; Kim D; Chung GE; Kim W; Kim JS Liver Int; 2017 Jun; 37(6):919-926. PubMed ID: 27917585 [TBL] [Abstract][Full Text] [Related]
7. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease. Suh JB; Kim SM; Cho GJ; Choi KM Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697 [TBL] [Abstract][Full Text] [Related]
8. [Significance of high sensitivity C-reactive protein level for predicting risk of nonalcoholic fatty liver in type 2 diabetes mellitus patients]. Jiang XZ; Wang JJ; Wu SL; Zhang YM; Zhang J; Wang JL; Duan HL; Li GJ; Wang Q Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):57-61. PubMed ID: 23663765 [TBL] [Abstract][Full Text] [Related]
9. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Dai YN; Zhu JZ; Fang ZY; Zhao DJ; Wan XY; Zhu HT; Yu CH; Li YM Metabolism; 2015 Dec; 64(12):1667-73. PubMed ID: 26476959 [TBL] [Abstract][Full Text] [Related]
10. Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study. Wolf RM; Steele KE; Peterson LA; Magnuson TH; Schweitzer MA; Wong GW PLoS One; 2015; 10(7):e0133955. PubMed ID: 26222183 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504 [TBL] [Abstract][Full Text] [Related]
12. The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease. Chung GE; Kim D; Kwak MS; Yang JI; Yim JY; Lim SH; Itani M Clin Mol Hepatol; 2016 Mar; 22(1):146-51. PubMed ID: 27044765 [TBL] [Abstract][Full Text] [Related]
13. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Zhu J; Wan X; Wang Y; Zhu K; Li C; Yu C; Li Y Endocrine; 2017 Apr; 56(1):208-211. PubMed ID: 27628583 [TBL] [Abstract][Full Text] [Related]
14. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease. Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721 [TBL] [Abstract][Full Text] [Related]
15. [Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study]. Bai JX; Shu RM; Huang Y; Peng Z Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):271-275. PubMed ID: 29996338 [No Abstract] [Full Text] [Related]
16. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Zhu JZ; Zhu HT; Dai YN; Li CX; Fang ZY; Zhao DJ; Wan XY; Wang YM; Wang F; Yu CH; Li YM Endocrine; 2016 Jan; 51(1):91-100. PubMed ID: 26362060 [TBL] [Abstract][Full Text] [Related]
17. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. Seo NK; Koo HS; Haam JH; Kim HY; Kim MJ; Park KC; Park KS; Kim YS J Gastroenterol Hepatol; 2015 Jul; 30(7):1211-6. PubMed ID: 25708291 [TBL] [Abstract][Full Text] [Related]
18. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. Chen LW; Chien CH; Kuo SF; Yu CY; Lin CL; Chien RN BMC Gastroenterol; 2019 Jul; 19(1):126. PubMed ID: 31311491 [TBL] [Abstract][Full Text] [Related]
19. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. Sayın O; Tokgöz Y; Arslan N J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600 [TBL] [Abstract][Full Text] [Related]
20. Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study. Wang J; Zhu W; Huang S; Xu L; Miao M; Wu C; Yu C; Li Y; Xu C Liver Int; 2017 Aug; 37(8):1202-1208. PubMed ID: 28106941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]